On February 29 at 1pm PT, the Lewy Body Dementia Association (LBDA, lbda.org) will host a webinar on “Introduction to Synuclein Biomarkers: How Researchers are ‘Seeing’ Lewy Bodies in the Living Brain.” Stanford neurologist Kathleen Poston, MD, will discuss recent advances in the development of biomarkers for alpha-synuclein, how they are changing research in Lewy body dementia (LBD) and Parkinson’s disease (PD), and how they may change clinical practice in the future.